FE 999913 vaginal tablet
000072
Phase 3 small_molecule completed
Quick answer
FE 999913 vaginal tablet for Luteal Hormone Supplementation is a Phase 3 program (small_molecule) at Ferring Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ferring Pharmaceuticals
- Indication
- Luteal Hormone Supplementation
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed